Sanofi: xbrl:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
| Value | {"unit": "EUR", "value": -82000000} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Sanofi |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:13:46.093769+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/8bdf2b3c-2f7a-4a04-9377-527e2ed31a2b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001121404-25-000010 · Open the official SEC filing →Retrieved: 2026-08-19T11:13:46.093769+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/8bdf2b3c-2f7a-4a04-9377-527e2ed31a2b
History
- no predecessors — first report